Biom Pharmaceutical
PrivateCompany Overview
Biom Pharmaceutical is a biotechnology company that develops microbiome-based nutritional supplements and therapeutic modalities for various diseases and age-related conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biom Pharmaceutical Comparables
Compare Biom Pharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Notitia Biotechnologies | 83% | |
| OptiBiotix Health Plc | 77% | |
| Solarea Bio | 75% | |
Biom Pharmaceutical Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 42% MoM.
- Nov 11, 2025
Monthly visitors increased 40% MoM.
Biom Pharmaceutical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biom Pharmaceutical's valuation, stock price, and market status.